Cancer clinical trials in the region Île-de-France

357 currently recruiting clinical trials
Region Île-de-France

Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR Targeted therapy
Systemic Treatment-Naive
Janssen
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR None Systemic Treatment-Naive
Janssen
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Locally Advanced EGFR None Chemotherapy Radiotherapy
AstraZeneca
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Localized ALK None Systemic Treatment-Naive Surgery
Hoffmann-La Roche
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Localized PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%) None Systemic Treatment-Naive
ALK EGFR
Bristol-Myers Squibb
Early Access Lung cancer
SCLC (Small Cell Lung Cancer) Localized Locally Advanced None Chemotherapy Radiotherapy Chemotherapy Radiotherapy
AstraZeneca
Phase 3 Bladder / Urinary Tract / Urethral cancer
#NCT06319820
Non-invasive bladder cancer Localized FGFR None 1 2 3 or more
Gustave Roussy (Villejuif), Hôpital Pitié Salpêtrière - AP-HP (Paris), Hôpital Saint Louis AP-HP (Paris), Hôpital Bichat - Claude Bernard - AP-HP (Paris)
Janssen
Phase 3 Bladder / Urinary Tract / Urethral cancer
#NCT05024773
Non-invasive bladder cancer Urothelial carcinoma Localized 1 Immunotherapy
Systemic Treatment-Naive Systemic Treatment-Naive
Hôpital Bichat - Claude Bernard - AP-HP (Paris)
Fidia Farmaceutici s.p.a.
Phase 3 Breast cancer
#NCT05552001
HER2 Negative HR Negative Locally Advanced Metastatic 1 Surgery Immunotherapy Chemotherapy Radiotherapy Surgery Chemotherapy Targeted therapy Radiotherapy
Systemic Treatment-Naive
Gustave Roussy (Villejuif)
Institut Gustave Roussy
Phase 3 Bladder / Urinary Tract / Urethral cancer
#NCT05911295
Invasive bladder cancer Upper excretory tract cancer Urethral cancer Urothelial carcinoma Locally Advanced Metastatic HER2 None Systemic Treatment-Naive
Immunotherapy
Gustave Roussy (Villejuif)
Seagen